ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Sees Significant Decline in Short Interest

Posted by Donna Armstrong on May 28th, 2026

ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 5,804 shares, a decline of 82.5% from the April 30th total of 33,182 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 29,325 shares, the short-interest ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Weiss Ratings began coverage on shares of ALPS Group Inc Ordinary Share in a research report on Wednesday, April 8th. They issued a “sell (e+)” rating for the company. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Get Our Latest Research Report on ALPS

ALPS Group Inc Ordinary Share Stock Up 1.6%

NASDAQ ALPS opened at $0.74 on Thursday. ALPS Group Inc Ordinary Share has a one year low of $0.56 and a one year high of $15.00. The stock has a market capitalization of $123.15 million, a PE ratio of 2.24 and a beta of -0.12.

ALPS Group Inc Ordinary Share Company Profile

(Get Free Report)

ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.